Terns Pharmaceuticals, Inc. (TERN) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Total Current Assets | 1.02B | 300.3M | 318.95M | 337.75M | 362.11M | 376.51M | 230.24M | 245.9M | 267.43M | 270.45M | 288.31M | 299.66M | 285.19M | 190.54M | 142.6M | 154.11M | 166.93M | 178.79M | 186.87M | 198.04M |
| Cash & Short-Term Investments | 1.02B | 295.63M | 315.44M | 334.26M | 358.16M | 372.78M | 225.3M | 240.65M | 263.44M | 266.6M | 285.6M | 297.53M | 283.11M | 187.29M | 139.81M | 151.27M | 165.98M | 177.2M | 185.08M | 195.58M |
| Cash Only | 524.75M | 150.7M | 145.97M | 139.02M | 161.44M | 270.14M | 91.5M | 65.1M | 79.93M | 37.89M | 80.92M | 184.35M | 143.24M | 62.98M | 16.81M | 43.88M | 47.7M | 64.75M | 67.59M | 98.83M |
| Short-Term Investments | 494.24M | 144.94M | 169.48M | 195.24M | 196.72M | 102.64M | 133.8M | 175.56M | 183.51M | 228.71M | 204.68M | 113.17M | 139.88M | 124.31M | 123M | 107.39M | 118.28M | 112.44M | 117.5M | 96.75M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.21M | 0 | 0 | 3.48M | 3.94M | 3.73M | 0 | 0 | 3.99M | 0 | 0 | 0 | 2.07M | 0 | 0 | 0 | 0 | 1.6M | 1.79M | 2.46M |
| Total Non-Current Assets | 884K | 1.36M | 1.46M | 1.57M | 1.82M | 1.73M | 642K | 871K | 1.08M | 1.23M | 1.38M | 1.62M | 1.84M | 2.05M | 2.26M | 2.56M | 1.14M | 1.1M | 1.14M | 1.2M |
| Property, Plant & Equipment | 884K | 997K | 1.11M | 1.22M | 1.47M | 1.67M | 587K | 816K | 1.03M | 1.2M | 1.35M | 1.58M | 1.8M | 2M | 2.19M | 2.49M | 1.05M | 927K | 959K | 1.02M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.01x | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 359K | 356K | 351K | 350K | 56K | 55K | 55K | 56K | 35K | 36K | 37K | 37K | 47K | 64K | 72K | 94K | 169K | 176K | 174K |
| Total Assets | 1.03B | 301.65M | 320.42M | 339.31M | 363.93M | 378.23M | 230.88M | 246.77M | 268.52M | 271.69M | 289.7M | 301.29M | 287.03M | 192.59M | 144.86M | 156.67M | 168.07M | 179.89M | 188.01M | 199.24M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.01x | - | - | - |
| Asset Growth % | 181.67% | -20.25% | 38.78% | 37.5% | 35.53% | 39.22% | -20.3% | -18.1% | -6.45% | 41.07% | 99.98% | 92.31% | 70.78% | 7.06% | -22.95% | -21.37% | 82.11% | 933.08% | - | - |
| Total Current Liabilities | 16.41M | 15.39M | 12.91M | 10.94M | 15.65M | 11.41M | 10.96M | 8.83M | 11.94M | 12.09M | 14.24M | 12.11M | 8.47M | 7.48M | 6.04M | 6.17M | 6.82M | 6.89M | 5.82M | 8.38M |
| Accounts Payable | 1.72M | 2.95M | 2.85M | 2.78M | 2.15M | 1.79M | 1.87M | 1.7M | 2.52M | 3.33M | 5.54M | 2.69M | 1.65M | 2.09M | 973K | 1.68M | 2.13M | 1.58M | 1.69M | 4.25M |
| Days Payables Outstanding | -1.99K | - | 2.37K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 836K | 836K | 836K |
| Other Current Liabilities | 7.37M | 940K | 461K | 3.19M | 5.16M | 4.76M | 320K | 532K | 5.96M | 392K | 280K | 363K | 185K | 308K | 149K | 271K | 358K | 3.08M | 2.34M | 2.79M |
| Current Ratio | 62.41x | 19.52x | 24.70x | 30.89x | 23.14x | 32.99x | 21.02x | 27.85x | 22.39x | 22.38x | 20.25x | 24.75x | 33.68x | 25.47x | 23.59x | 25.00x | 24.48x | 25.94x | 32.12x | 23.64x |
| Quick Ratio | 62.41x | 19.52x | 24.70x | 30.89x | 23.14x | 32.99x | 21.02x | 27.85x | 22.39x | 22.38x | 20.25x | 24.75x | 33.68x | 25.47x | 23.59x | 25.00x | 24.48x | 25.94x | 32.12x | 23.64x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 2.14M | 2.2M | 2.27M | 2.34M | 2.41M | 2.35M | 1.24M | 1.22M | 1.21M | 1.18M | 1.31M | 1.49M | 1.61M | 1.41M | 1.6M | 1.79M | 947K | 841K | 857K | 862K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 445K | 570K | 689K | 806K | 919K | 1.03M | 0 | 0 | 0 | 63K | 223K | 386K | 544K | 702K | 851K | 1M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.7M | 1.63M | 1.58M | 1.53M | 1.49M | 1.32M | 1.24M | 1.22M | 1.21M | 1.11M | 1.09M | 1.11M | 1.07M | 709K | 749K | 788K | 947K | 841K | 857K | 862K |
| Total Liabilities | 18.55M | 17.59M | 15.19M | 13.27M | 18.06M | 13.76M | 12.2M | 10.05M | 13.15M | 13.26M | 15.55M | 13.6M | 10.08M | 8.89M | 7.64M | 7.95M | 7.77M | 7.73M | 6.67M | 9.24M |
| Total Debt | 919K | 1.03M | 1.13M | 1.24M | 1.35M | 1.3M | 249K | 427K | 603K | 770K | 876K | 1.04M | 1.21M | 1.37M | 1.44M | 1.58M | 0 | 0 | 0 | 0 |
| Net Debt | -523.83M | -149.67M | -144.83M | -137.79M | -160.09M | -268.83M | -91.25M | -64.67M | -79.32M | -37.12M | -80.04M | -183.31M | -142.03M | -61.61M | -15.37M | -42.3M | -47.7M | -64.75M | -67.59M | -98.83M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 1.01B | 284.07M | 305.23M | 326.04M | 345.87M | 364.47M | 218.68M | 236.72M | 255.37M | 258.43M | 274.15M | 287.68M | 276.94M | 183.69M | 137.22M | 148.72M | 160.3M | 172.16M | 181.33M | 190M |
| Equity Growth % | 191.01% | -22.06% | 39.58% | 37.73% | 35.44% | 41.04% | -20.23% | -17.71% | -7.79% | 40.68% | 99.79% | 93.44% | 72.76% | 6.7% | -24.33% | -21.73% | 133.71% | 792.84% | - | 936.9% |
| Book Value per Share | 10.80 | 3.10 | 3.33 | 3.56 | 3.79 | 4.68 | 2.94 | 3.18 | 3.53 | 3.61 | 3.84 | 4.12 | 5.06 | 4.77 | 5.42 | 5.89 | 6.34 | 6.85 | 7.22 | 7.56 |
| Total Shareholders' Equity | 1.01B | 284.07M | 305.23M | 326.04M | 345.87M | 364.47M | 218.68M | 236.72M | 255.37M | 258.43M | 274.15M | 287.68M | 276.94M | 183.69M | 137.22M | 148.72M | 160.3M | 172.16M | 181.33M | 190M |
| Common Stock | 11K | 9K | 9K | 9K | 9K | 8K | 7K | 6K | 6K | 6K | 6K | 5K | 5K | 4K | 3K | 3K | 3K | 3K | 3K | 3K |
| Retained Earnings | -517.69M | -494.12M | -469.48M | -445.39M | -421.48M | -399.68M | -377.74M | -355M | -332.63M | -311.61M | -281.84M | -263.95M | -242.42M | -226.6M | -209.78M | -195.85M | -182.07M | -167.82M | -155.99M | -145.25M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 260K | 109K | -22K | 51K | -279K | 160K | -443K | -321K | -19K | -836K | -775K | -416K | -822K | -1.35M | -1.24M | -896K | -338K | -167K | -174K | -232K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |